BioCentury
ARTICLE | Company News

Memory Pharmaceuticals, Roche deal

December 8, 2008 8:00 AM UTC

Roche will acquire partner Memory in a tender offer of $0.61 per share in cash, or about $50 million. The price is a 307% premium to Memory's close of $0.15 on Nov. 24, the day before the deal was ann...